LOGO changes.png

(703) 627-1934

The First and Only Long-Acting Loop Diuretic for the Treatment of Heart Failure  

*SOANZXR   is developed to treat:

TM

Edema associated with Congestive Heart Failure and Kidney Disease

Ascites caused by Hepatitis and Liver Cirrhosis

Hypertension

Immediate Release Loop Diuretics:

  • Have a very short duration of action.

  • Most patients remain volume overloaded.

Volume Overload Causes:

‚Äč

  • High rates of hospitalization and readmissions.

  • Costing billions of dollars to the healthcare system. 

Benefits of SOANZXR  :

TM

  • An extended-release oral tablet with a significantly longer duration of action compared to immediate-release loop diuretics.

  • The action of SOANZXR   extends for most of the day and induces gradual and sustained urination.

  • SOANZXR   improves the quality of life for patients in many ways, including incontinence.

TM

TM

*SOANZXR   is not yet approved by the FDA. The target date of approval is expected to be January 14, 2020.

TM

Follow

  • Facebook
  • Twitter

Contact

(703) 627-1934

Address

8000 Towers Cresent Drive

Suite 1388

Vienna, VA 22182

©2019 by Sarfez Pharmaceuticals, Inc.